UNICHEM LAB Q3 Profit Soars 4x to ₹264 Crore, Driven by One-Time Gain

• UNICHEM LAB announced its Q3 results, reporting a significant increase in consolidated profit from ₹58 crore to ₹264 crore year-on-year.
• The substantial profit surge was primarily attributed to a one-time gain of ₹276 crore.
• Despite the profit jump, UNICHEM LAB's consolidated revenue decreased from ₹533 crore to ₹521 crore, and EBITDA fell from ₹87 crore to ₹44 crore.
• UNICHEM LAB's stock closed at ₹423.25, up 1.39% (5.80 points) in today's trading session.
• Alembic Pharmaceuticals Ltd. also reported Q3 results, with consolidated revenue increasing to ₹1,876 crore and EBITDA rising to ₹294 crore, though net profit slightly decreased.